Ono Pharmaceutical (United States)
In research, Ono Pharmaceutical (United States) stands highest in Medicine (#7,357 of 8,541 worldwide) and Health Sciences (#8,923 of 9,902 worldwide), 2022-now.
- World rank, 2022-now
- #21,297 of 22,385 · #11,660 all time
- Rank in United States
- #3,149 of 3,332
- Research works
- 1.3k ▼ 12% vs 2018-21
- Citations
- 41k 31.4 per fractional work
- Top-10% rate
- 13.9% all institutions 10.0%
- vs its own fields
- 0.98× 1.00× is exactly expected
- Open access
- 26% world 40%
- International
- 26% world 18%
What is Ono Pharmaceutical (United States) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #7,357 of 8,541 | 14.9% | 61 | #8657 | |
| Health SciencesDomain | #8,923 of 9,902 | 14.5% | 63 | #10054 |
Each strip is that field's whole ranked pool, with the notch where Ono Pharmaceutical (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which fields of science does Ono Pharmaceutical (United States) work in?
In 2022-now, 57% of research at Ono Pharmaceutical (United States) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (5%). It does 2.3× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 22 fields, with their numbers
- Health Sciences6857.0%
- Medicine6655.2%
- Health Professions21.6%
- Nursing00.1%
- Veterinary00.0%
- Life Sciences2924.3%
- Physical Sciences1411.7%
- Chemistry54.3%
- Engineering32.3%
- Mathematics21.9%
- Computer Science21.9%
- Materials Science11.2%
- Environmental Science00.1%
- Physics and Astronomy00.1%
- Social Sciences87.0%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.9×. Every wedge is a field page.
All 22 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics9.88×4 works
- Immunology and Microbiology4.85×6 works
- Medicine2.87×66 works
- Chemistry2.76×5 works
- Biochemistry, Genetics and Molecular Biology2.71×17 works
- Economics, Econometrics and Finance1.97×5 works
- Mathematics1.61×2 works
- Health Professions0.61×2 works
- Decision Sciences0.59×1 works
- Neuroscience0.47×1 works
- Materials Science0.33×1 works
- Veterinary0.29×0 works
- Computer Science0.24×2 works
- Nursing0.21×0 works
- Psychology0.16×1 works
- Agricultural and Biological Sciences0.15×1 works
- Engineering0.15×3 works
- Social Sciences0.11×2 works
- Arts and Humanities0.07×0 works
- Physics and Astronomy0.03×0 works
- Business, Management and Accounting0.03×0 works
- Environmental Science0.02×0 works
- Pharmacology, Toxicology and Pharmaceutics 9.9×
- Immunology and Microbiology 4.8×
- Medicine 2.9×
- Chemistry 2.8×
- Biochemistry, Genetics and Molecular Biology 2.7×
- Economics, Econometrics and Finance 2.0×
- Mathematics 1.6×
- Health Professions 0.6×
- Decision Sciences 0.6×
- Neuroscience 0.5×
- Materials Science 0.3×
- Veterinary 0.3×
- Computer Science 0.2×
- Nursing 0.2×
- Psychology 0.2×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
- Social Sciences 0.1×
- Arts and Humanities 0.1×
- Physics and Astronomy 0.0×
- Business, Management and Accounting 0.0×
- Environmental Science 0.0×
Who are the top researchers at Ono Pharmaceutical (United States)?
Ranked on the quality score, Steve Arkinstall, Stephen S. Palmer and Bo Marelli lead among researchers whose main affiliation is Ono Pharmaceutical (United States).
- 1
Steve Arkinstall
United States · #986,031 worldwide 5k citations · 38 works
- 2
Stephen S. Palmer
United States · #993,948 worldwide 2.5k citations · 83 works
- 3
Bo Marelli
United States · #995,153 worldwide 963 citations · 45 works
- 4
Xuliang Jiang
United States · #1,093,100 worldwide 2.4k citations · 60 works
- 5
David Fischer
United States · #1,425,537 worldwide 2k citations · 45 works
- 6
Berend Neuteboom
United States · #1,766,340 worldwide 1.1k citations · 20 works
- 7
Herbert L. Stone
United States · #1,920,703 worldwide 2.9k citations · 21 works
- 8
Gabriela P. Saborı́o
United States · #2,250,492 worldwide 2.6k citations · 16 works
- 9
Vanita D. Sood
United States · #2,272,339 worldwide 740 citations · 25 works
- 10
Jean-Marie Cuillerot
United States · #2,329,926 worldwide 2.1k citations · 42 works
Which keywords describe research at Ono Pharmaceutical (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Molecular Characterization, Neoadjuvant Therapy, Clinical Trials, Targeted Therapy, Tumor Microenvironment and Guidelines.
- Anticancer Agents
- Cost-effectiveness Analysis
- Homologous Recombination
- Metastasis
- Antibody Engineering
- Precision Medicine
- Medicinal Chemistry
- EGFR Mutations
- Biomarkers
- PD-1 and PD-L1
- Therapeutic Antibodies
- Pharmacokinetics
- Quality of Life
- Prognostic Factors
- Urothelial Carcinoma
- Guidelines
- Tumor Microenvironment
- Cancer
- Neoadjuvant Therapy
- Immunotherapy
- Chemotherapy
- Molecular Characterization
- Clinical Trials
- Targeted Therapy
- Inflammation
- Bladder Cancer
- Machine Learning
- Cancer Therapy
- Monoclonal Antibodies
- Glycosylation
- Immune Checkpoint Blockade
- Autoantibodies
- ALK Inhibitors
- Genomic Profiling
- Genomic Instability
- Cell Death
- Fc Receptors
- Cognitive Impairment
- Cancer Incidence
- Health Utility Measures
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy13▲ 15×15 topics
- Immunotherapy11▲ 12×13 topics
- Molecular Characterization8▲ 38×4 topics
- Neoadjuvant Therapy7▲ 25×5 topics
- Clinical Trials7▲ 8.7×9 topics
- Cancer7▲ 4.3×23 topics
- Targeted Therapy7▲ 25×4 topics
- Tumor Microenvironment6▲ 12×7 topics
- Inflammation6▲ 2.5×24 topics
- Guidelines6▲ 11×2 topics
- Bladder Cancer6▲ 132×1 topic
- Urothelial Carcinoma6▲ 114×1 topic
- Machine Learning6▲ 1.41×12 topics
- Prognostic Factors6▲ 11×7 topics
- Cancer Therapy5▲ 6.9×11 topics
- Quality of Life5▲ 2.6×9 topics
- Monoclonal Antibodies4▲ 41×3 topics
- Pharmacokinetics4▲ 11×6 topics
- Glycosylation4▲ 27×3 topics
- Therapeutic Antibodies4▲ 42×2 topics
- Immune Checkpoint Blockade3▲ 25×1 topic
- PD-1 and PD-L13▲ 25×1 topic
- Autoantibodies3▲ 12×7 topics
- Biomarkers3▲ 3.9×6 topics
- ALK Inhibitors3▲ 41×1 topic
- EGFR Mutations3▲ 41×1 topic
- Genomic Profiling3▲ 25×2 topics
- Medicinal Chemistry3▲ 9.6×4 topics
- Genomic Instability3▲ 22×3 topics
- Precision Medicine3▲ 5.1×4 topics
- Cell Death3▲ 9.9×5 topics
- Antibody Engineering3▲ 42×1 topic
- Fc Receptors3▲ 42×1 topic
- Metastasis3▲ 6.5×8 topics
- Cognitive Impairment2▲ 8.2×5 topics
- Homologous Recombination2▲ 44×2 topics
- Cancer Incidence2▲ 15×3 topics
- Cost-effectiveness Analysis2▲ 25×1 topic
- Health Utility Measures2▲ 25×1 topic
- Anticancer Agents2▲ 12×6 topics
Which research topics does Ono Pharmaceutical (United States) publish most on?
By volume in 2022-now: Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Bladder and Urothelial Cancer Treatments Surgery 6 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 6 Systemic Lupus Erythematosus Research Rheumatology 2 works
- 7 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
- 8 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 2 works
- 9 Cancer Genomics and Diagnostics Cancer Research 2 works
- 10 Statistical Methods in Clinical Trials Statistics and Probability 2 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Ono Pharmaceutical (United States)'s research output changed?
Output in 2022-2025 was 12% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Ono Pharmaceutical (United States) as a percentage of every work published that year, 0.00043% in 2024.
Fractional works of Ono Pharmaceutical (United States) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 26.0% in 2024.
Other research institutions in Trenton
- New Jersey Department of Health
- Windsor Dermatology
- New Jersey Department of Environmental Protection
- Medical Diagnostic Laboratories (United States)
- Universal Display Corporation
- New Jersey Department of Transportation
- Thomas Edison State University
- St. Francis Medical Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Ono Pharmaceutical (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
